About
Monoclonal Antibody
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySouthwestern U.S.
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
170
By Phase
NA: 3
By Status
RECRUITING: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05679622Lead Sponsor
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
NARecruiting
30 participants
Started: Dec 1, 2022 · Completed: Jun 30, 2025
NCT05753774Lead Sponsor
Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders
NARecruiting
100 participants
Started: Aug 1, 2022 · Completed: Aug 1, 2026
NCT05321745Lead Sponsor
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
NARecruiting
40 participants
Started: Mar 22, 2022 · Completed: May 31, 2026
Locations (1)
Headquarters
Henderson, NV, United States
Map
Loading map...